An overview of targets and therapies for glioblastoma multiforme

Area of Science:

• Neuro-oncology
• Clinical Trials
• Palliative Care

Background:

• Glioblastoma multiforme (GBM) predominantly affects older adults (>65 years) and is associated with a poor median survival rate.
• Current therapeutic strategies for GBM are limited, necessitating the exploration of novel treatment approaches.
• Effective diagnosis and palliative care remain significant challenges in managing GBM patients.

Purpose of the Study:

• To provide a comprehensive overview of the current clinical trial landscape for Glioblastoma multiforme.
• To highlight emerging therapeutic targets, repurposed drugs, and innovative technologies for GBM treatment.
• To emphasize the importance of advanced diagnostic tools, including artificial intelligence, and dynamic palliative care strategies for GBM.

Main Methods:

• Literature review of current clinical trials for Glioblastoma multiforme.
• Analysis of emerging therapeutic targets and drug repurposing strategies.
• Exploration of technological advancements in GBM diagnosis, imaging, and patient care.

Main Results:

• The review identifies several promising new targets and repurposed drugs currently under investigation for GBM.
• Technological advancements, including AI in diagnosis and imaging, show potential for improving GBM management.
• There is a critical need for developing dynamic palliative care strategies tailored to end-of-life GBM patient management.

Conclusions:

• The current clinical trial scenario for Glioblastoma multiforme offers potential for improved therapeutic outcomes.
• Integrating advanced technologies and artificial intelligence can enhance GBM diagnosis and treatment efficacy.
• A proactive and dynamic approach to palliative care is essential for improving the quality of life for GBM patients.